SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-036093
Filing Date
2020-06-11
Accepted
2020-06-11 19:44:08
Documents
2
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6763
2 POA DOCUMENT poa.txt EX-24.3_921761 3051
  Complete submission text file 0001209191-20-036093.txt   11233
Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VAXCYTE, INC. 353 HATCH DRIVE FOSTER CITY CA 94404
Business Address
Fairman Jeff (Reporting) CIK: 0001813800 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39323 | Film No.: 20958471